Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Age Source
Steve Forte Also a director
EVP, CHIEF FINANCIAL OFFICER
Title from the Form 4 dated Jan 28, 2026
46
Sandra Isabelle Barros Alves
SVP, Finance and CAO
Title from the Form 4 dated Jan 28, 2026
Not stated
Alves
Senior Vice President, Chief Accounting Officer and principal accounting officer
Not stated
Jon Adkins Also a director
Executive officer
Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 29, 2025 · updated by the 8-K of Jan 28, 2026

Directors
9
serving now
Independent
7 of 8
stated in the proxy; 1 not stated
Average tenure
3.8 years
from year joined
CEO also chairs the board
No
Thomas Civik
Director Age On board Independent Committees Other public boards 2024 pay Source
Thomas Civik
56 2021
4 years
Independent None stated Pyxis Oncology, Inc. $149,201
Steve Forte
46 2025
this year
Not independent None stated None stated Paid as CEO
David Bonita, M.D.
49 2019
6 years
Independent
Compensation Science and Technology
Acutus Medical Inc., Ikena Oncology, Inc., Prelude Therapeutics Inc., Third Harmonic Bio, Inc. $119,060
Carol A. Schafer
61 2019
6 years
Independent
Nominating and Corporate Governance · Chair
Immunome, Inc., Insmed, Inc, Kura Oncology, Inc. $128,806
Steven Stein, M.D.
58 2024
1 year
Independent None stated None stated $172,311
Samarth Kulkarni, Ph.D.
46 2019
6 years
Independent None stated Black Diamond Therapeutics, Inc., Oruka Therapeutics, Centessa Pharmaceuticals plc $118,430
Susan M. Molineaux, Ph.D.
71 2023
2 years
Independent None stated Geron Corporation $122,847
Ann D. Rhoads
59 2020
5 years
Independent
Audit · Chair
Globus Medical Inc., QuidelOrtho Corporation (formerly Quidel Corporation), iTeos Therapeutics Inc. $130,138
Jon Adkins Joined Jan 28, 2026
- - - - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 29, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support